Throughout his presidential campaign, President Trump championed the need to allow the government to negotiate drug prices on behalf of the Medicare program. However, that third rail for pharmaceutical companies was not...more
5/22/2018
/ Competition ,
Drug Pricing ,
Generic Drugs ,
Life Sciences ,
Medicare Part D ,
Out-of-Pocket Expenses ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Reform ,
Trump Administration
President Trump has been clear in his intention to repeal the ACA. In fact, among President Trump’s first executive orders was one seeking to “minimize the economic burden” associated with the Patient Protection and...more
1/24/2017
/ Affordable Care Act ,
American Hospital Association ,
EHR ,
Employee Benefits ,
Employer Mandates ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Hospitals ,
Meaningful Use ,
Regulatory Oversight ,
Repeal ,
Trump Administration
The American Hospital Association, after having been “nice” all year, penned its letter to Santa Claus with its wish list for Christmas. Its four page letter (actually addressed to President-Elect Donald Trump at 1717...more
1/10/2017
/ ACOs ,
Affordable Care Act ,
American Hospital Association ,
Anti-Kickback Statute ,
Children's Health Insurance Program (CHIP) ,
Department of Justice (DOJ) ,
EHR ,
Federal Trade Commission (FTC) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Home Health Agencies ,
Hospitals ,
Meaningful Use ,
Medical Malpractice ,
Medical Reimbursement ,
Medicare ,
Medicare Part A ,
Medicare Part B ,
Mergers ,
Patient Safety ,
Regulatory Oversight ,
Safe Harbors ,
Section 340B ,
Stark Law ,
Telehealth ,
Trump Administration